|
VRNA Verona Pharma Plc 1657312 |
| Balance Sheet |
|
Current Assets
|
364,253,000 |
|
Assets
|
381,818,000 |
|
Current Liabilities
|
27,950,000 |
|
Liabilities
|
251,327,000 |
|
Equity
|
130,491,000 |
|
Shares Out
|
649,881,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-93,367,000 |
|
Investing Cash Flow
|
-45,000 |
| Market Analysis |
Market Cap
|
2,405,372,841 |
|
Price
|
51.89 |
|
BVPS
|
0.20 |
|
PB
|
255.33 |
|
EPS
|
-1.55 |
|
PS
|
1.62 |
|
FCF
|
-93,412,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRNA documents filed with the SEC.
VRNA Filings
Clear
